Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,559 | 28,634 | 43,482 | 61,991 | 44,848 |
| Marketable Securities | 212,093 | 222,457 | 227,321 | 200,263 | 104,410 |
| TOTAL | $255,597 | $259,818 | $279,316 | $266,420 | $151,787 |
| Non-Current Assets | |||||
| PPE Net | 16,151 | 16,323 | 15,507 | 13,859 | 7,241 |
| Investments And Advances | 22,199 | 32,305 | 39,086 | 77,707 | 108,116 |
| Other Non-Current Assets | 2,713 | 8,595 | 2,535 | 2,836 | 4,168 |
| TOTAL | $41,063 | $57,223 | $57,128 | $94,402 | $119,525 |
| Total Assets | $296,660 | $317,041 | $336,444 | $360,822 | $271,312 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,849 | 4,379 | 3,104 | 5,711 | 3,511 |
| Accrued Expenses | 8,454 | 5,552 | 6,411 | 4,359 | 5,855 |
| Other current liabilities | 106 | 961 | 110 | 835 | 763 |
| TOTAL | $62,551 | $62,849 | $78,860 | $87,568 | $90,673 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 51,142 | 51,957 | 69,235 | 76,663 | 80,544 |
| Other Non-Current Liabilities | 1,982 | 1,938 | 4,086 | 4,448 | 3,429 |
| TOTAL | $67,000 | $79,130 | $82,076 | $95,299 | $110,689 |
| Total Liabilities | $129,551 | $141,979 | $160,936 | $182,867 | $201,362 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,392 | 32,246 | 32,194 | 32,171 | N/A |
| Common Shares | 32 | 32 | 32 | 32 | 2 |
| Retained earnings | -89,615 | -80,251 | -76,167 | -72,787 | -73,172 |
| Other shareholders' equity | -409 | -344 | -552 | -486 | 138,605 |
| TOTAL | $167,109 | $175,062 | $175,508 | $177,955 | $69,950 |
| Total Liabilities And Equity | $296,660 | $317,041 | $336,444 | $360,822 | $271,312 |